Locations:
Search
Helping cancer patients survive and thrive
This cell surface protein could be an immune checkpoint inhibition target
Better assessing individual risk of recurrence
Test can identify aggressive vs. indolent disease, reduce unneeded biopsies
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Survey results reveal need for further education
Case report: Primary laryngeal NK/T-cell lymphoma
Research examines risk factors
Findings may help explain poor prognosis in this population
Cleveland Clinic study finds it’s safe and effective
Add prophylaxis for patients receiving systemic therapy
Advertisement
Advertisement